Lyzogub V H, Sobol' V O, Moshkovs'ka Iu O, Bondarchuk O M
Lik Sprava. 2014 May-Jun(5-6):67-72.
The article analyzes the results of studying the effects of antihypertensive treatment with the use of agonists dopamine receptors on clinical and hemodynamic and neurohumoral indicators in hypertensive patients with concomitant obesity. Special role is given to the patogenetice factor as dopamine and his relationship with the renin - angiotensin.- aldosterone system, endothelial function, which are aimed at the regulation of blood pressure and obesity formation and progression.
本文分析了使用多巴胺受体激动剂进行降压治疗对伴有肥胖的高血压患者临床、血流动力学和神经体液指标的影响研究结果。特别强调了多巴胺这一发病机制因素及其与肾素 - 血管紧张素 - 醛固酮系统、内皮功能的关系，这些因素旨在调节血压以及肥胖的形成和进展。
